Jeffrey Segal

CIK 1832552 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 5, 2021 · Latest: Jan. 5, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 31, 2020 IVF A 11,823 11,823 Direct Acquired (price as of 2026-08-20)
Dec. 31, 2020 IVF A 8,838 9,975 Direct +777.31% Acquired (price as of 2026-08-20)
Nov. 27, 2020 IVF A 1,137 1,137 Direct Acquired (price as of 2026-08-20)
Nov. 27, 2020 IVF A 1,137 1,137 Direct Acquired (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 31, 2020 IVF Stock Option Common Stock (11,823) $3.06 Dec. 31, 2030 11,823 Acquired
Nov. 27, 2020 IVF Stock Option Common Stock (1,137) $3.19 Nov. 27, 2025 1,137 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).